Literature DB >> 25493329

Dissecting the molecular mechanism of apoptosis during photothermal therapy using gold nanoprisms.

Marta Pérez-Hernández1, Pablo Del Pino, Scott G Mitchell, María Moros, Grazyna Stepien, Beatriz Pelaz, Wolfgang J Parak, Eva M Gálvez, Julián Pardo, Jesús M de la Fuente.   

Abstract

The photothermal response of plasmonic nanomaterials can be exploited for a number of biomedical applications in diagnostics (biosensing and optoacoustic imaging) and therapy (drug delivery and photothermal therapy). The most common cellular response to photothermal cancer treatment (ablation of solid tumors) using plasmonic nanomaterials is necrosis, a process that releases intracellular constituents into the extracellular milieu producing detrimental inflammatory responses. Here we report the use of laser-induced photothermal therapy employing gold nanoprisms (NPRs) to specifically induce apoptosis in mouse embryonic fibroblast cells transformed with the SV40 virus. Laser-irradiated "hot" NPRs activate the intrinsic/mitochondrial pathway of apoptosis (programmed cell death), which is mediated by the nuclear-encoded proteins Bak and Bax through the activation of the BH3-only protein Bid. We confirm that an apoptosis mechanism is responsible by showing how the NPR-mediated cell death is dependent on the presence of caspase-9 and caspase-3 proteins. The ability to selectively induce apoptotic cell death and to understand the subsequent mechanisms provides the foundations to predict and optimize NP-based photothermal therapy to treat cancer patients suffering from chemo- and radioresistance.

Entities:  

Keywords:  Bcl-2 family; NIR window; apoptosis; gold nanoparticles; mitochondrial pathway; nanoprism; photothermal

Mesh:

Substances:

Year:  2014        PMID: 25493329     DOI: 10.1021/nn505468v

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  72 in total

Review 1.  Diverse Applications of Nanomedicine.

Authors:  Beatriz Pelaz; Christoph Alexiou; Ramon A Alvarez-Puebla; Frauke Alves; Anne M Andrews; Sumaira Ashraf; Lajos P Balogh; Laura Ballerini; Alessandra Bestetti; Cornelia Brendel; Susanna Bosi; Monica Carril; Warren C W Chan; Chunying Chen; Xiaodong Chen; Xiaoyuan Chen; Zhen Cheng; Daxiang Cui; Jianzhong Du; Christian Dullin; Alberto Escudero; Neus Feliu; Mingyuan Gao; Michael George; Yury Gogotsi; Arnold Grünweller; Zhongwei Gu; Naomi J Halas; Norbert Hampp; Roland K Hartmann; Mark C Hersam; Patrick Hunziker; Ji Jian; Xingyu Jiang; Philipp Jungebluth; Pranav Kadhiresan; Kazunori Kataoka; Ali Khademhosseini; Jindřich Kopeček; Nicholas A Kotov; Harald F Krug; Dong Soo Lee; Claus-Michael Lehr; Kam W Leong; Xing-Jie Liang; Mei Ling Lim; Luis M Liz-Marzán; Xiaowei Ma; Paolo Macchiarini; Huan Meng; Helmuth Möhwald; Paul Mulvaney; Andre E Nel; Shuming Nie; Peter Nordlander; Teruo Okano; Jose Oliveira; Tai Hyun Park; Reginald M Penner; Maurizio Prato; Victor Puntes; Vincent M Rotello; Amila Samarakoon; Raymond E Schaak; Youqing Shen; Sebastian Sjöqvist; Andre G Skirtach; Mahmoud G Soliman; Molly M Stevens; Hsing-Wen Sung; Ben Zhong Tang; Rainer Tietze; Buddhisha N Udugama; J Scott VanEpps; Tanja Weil; Paul S Weiss; Itamar Willner; Yuzhou Wu; Lily Yang; Zhao Yue; Qian Zhang; Qiang Zhang; Xian-En Zhang; Yuliang Zhao; Xin Zhou; Wolfgang J Parak
Journal:  ACS Nano       Date:  2017-03-14       Impact factor: 15.881

2.  Playing with nanoparticle shapes and laser powers to decide which route to take during photothermal therapy: apoptosis or necrosis?

Authors:  Claudia Tortiglione; Roberta Iachetta
Journal:  Ann Transl Med       Date:  2016-10

3.  IR820-loaded PLGA nanoparticles for photothermal therapy of triple-negative breast cancer.

Authors:  Danielle M Valcourt; Megan N Dang; Emily S Day
Journal:  J Biomed Mater Res A       Date:  2019-04-09       Impact factor: 4.396

Review 4.  Photothermal therapies to improve immune checkpoint blockade for cancer.

Authors:  Preethi B Balakrishnan; Elizabeth E Sweeney; Anvitha S Ramanujam; Rohan Fernandes
Journal:  Int J Hyperthermia       Date:  2020-12       Impact factor: 3.914

5.  Spatial modulation spectroscopy for imaging and quantitative analysis of single dye-doped organic nanoparticles inside cells.

Authors:  Mary Sajini Devadas; Tuphan Devkota; Samit Guha; Scott K Shaw; Bradley D Smith; Gregory V Hartland
Journal:  Nanoscale       Date:  2015-06-07       Impact factor: 7.790

Review 6.  Gold nanoparticle-mediated photothermal therapy: applications and opportunities for multimodal cancer treatment.

Authors:  Rachel S Riley; Emily S Day
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2017-02-03

7.  Efficacy, long-term toxicity, and mechanistic studies of gold nanorods photothermal therapy of cancer in xenograft mice.

Authors:  Moustafa R K Ali; Mohammad Aminur Rahman; Yue Wu; Tiegang Han; Xianghong Peng; Megan A Mackey; Dongsheng Wang; Hyung Ju Shin; Zhuo G Chen; Haopeng Xiao; Ronghu Wu; Yan Tang; Dong M Shin; Mostafa A El-Sayed
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-29       Impact factor: 11.205

8.  Hybrid Theranostic Platform for Second Near-IR Window Light Triggered Selective Two-Photon Imaging and Photothermal Killing of Targeted Melanoma Cells.

Authors:  Christine Tchounwou; Sudarson Sekhar Sinha; Bhanu Priya Viraka Nellore; Avijit Pramanik; Rajashekhar Kanchanapally; Stacy Jones; Suhash Reddy Chavva; Paresh Chandra Ray
Journal:  ACS Appl Mater Interfaces       Date:  2015-09-08       Impact factor: 9.229

9.  Multimodal Nonlinear Optical Imaging of Live Cells Using Plasmon-Coupled DNA-Mediated Gold Nanoprism Assembly.

Authors:  Sudarson Sekhar Sinha; Stacy Jones; Teresa Demeritte; Suhash Reddy Chavva; Yongliang Shi; Jasmine Burrell; Avijit Pramanik; Paresh Chandra Ray
Journal:  J Phys Chem C Nanomater Interfaces       Date:  2016-02-19       Impact factor: 4.126

Review 10.  Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer.

Authors:  Yijing Liu; Pravin Bhattarai; Zhifei Dai; Xiaoyuan Chen
Journal:  Chem Soc Rev       Date:  2019-04-01       Impact factor: 54.564

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.